Feline Infectious Peritonitis: Hope After a Death Sentence Diagnosis

Feline infectious peritonitis (FIP) was once invariably fatal in cats. The development of effective antiviral treatments has transformed it from a death sentence into a treatable disease, representing one of the most significant recent advances in feline medicine.

Key Facts

FIP is caused by a virulent mutation of feline coronavirus (FCoV) that transforms from a common gut virus into a systemic, immune-evading pathogen; the mutation occurs within individual cats and is not typically transmitted between cats in its virulent form
FIP occurs in two primary forms: "wet" (effusive) FIP with fluid accumulation in the chest or abdomen, and "dry" (non-effusive) FIP with granulomatous lesions in organs and increasingly common neurological or ocular involvement
Until 2019, FIP was essentially 100% fatal; there was no effective treatment and diagnosis itself was a terminal prognosis
Nucleoside analogue antivirals — particularly GS-441524 (the active metabolite of remdesivir) and molnupiravir — have transformed FIP outcomes; clinical trial data shows 80-90% survival rates in treated cats
GS-441524 is not yet licensed for veterinary use in most countries, meaning access depends on compounded or imported products from manufacturers primarily in China; regulatory barriers have created significant geographic and cost inequalities in access
Treatment requires 84 days of daily injection or oral dosing followed by 12 weeks of observation; neurological FIP typically requires higher doses and longer treatment courses with lower (though improving) remission rates
Cost is a significant welfare barrier: treatment can cost $3,000-8,000+ in countries without licensed access, placing effective treatment out of reach for many cat owners
UK and European regulatory agencies are progressively licensing FIP antivirals, with Eurifel and other branded formulations becoming available; this is gradually improving access and reducing cost

Welfare Considerations

FIP has moved from a condition causing inevitable death after a period of progressive suffering to a treatable disease where most cats can achieve full clinical remission — a transformation that saves enormous suffering. The welfare implications of this shift are profound: cats diagnosed with FIP and treated promptly avoid the prolonged deterioration that was previously inevitable. Untreated FIP causes real suffering: ascitic fluid accumulation causes abdominal discomfort and breathing difficulty; neurological FIP causes seizures, incoordination, and disorientation; and the systemic immune dysregulation causes pain, weight loss, and malaise. The remaining welfare challenge is inequity of access: the availability of effective treatment that varies dramatically by geography and financial resources means that some cats who could be saved are not, while others in wealthier households receive life-saving treatment. Advocacy for licensing and affordable access to FIP antivirals is therefore a concrete animal welfare intervention with measurable lives-at-stake consequences.

What You Can Do

If your cat is diagnosed with FIP, seek referral to a feline specialist or FIP-experienced vet immediately — treatment is highly time-sensitive and improves outcomes dramatically when started early
Join owner support groups (FIP Warriors, FIP UK Support) that provide practical guidance on treatment sourcing, protocol management, and monitoring — the owner community has developed remarkable expertise
Advocate for accelerated licensing of FIP antivirals in your country — regulatory delay costs cat lives; writing to veterinary regulatory bodies and supporting organisations lobbying for licensing is a concrete action
Donate to FIP treatment funds that help owners who cannot afford the full cost of treatment — several country-specific charitable funds exist to support access for cats whose owners face financial barriers
Support feline coronavirus research to better understand mutation triggers and explore whether vaccination or other interventions could prevent FIP development in FCoV-positive cats
If your cat is FCoV-positive (a very common finding in multi-cat households), manage stress and overcrowding to reduce viral mutation risk, and ensure annual FCoV antibody titre monitoring